Creative Testing Solutions

Form 483 issued August 29, 2025 · Tempe, Arizona

Inspection
Aug 18 – Aug 29, 2025
Observations
2
Pages
4
FEI number
3000204058

In short: On August 29, 2025, FDA issued a Form 483 with 2 observations to Creative Testing Solutions in Tempe, Arizona (FEI 3000204058) after an inspection that ran Aug 18 – Aug 29, 2025. The investigators were Emily S. McGann and William F. Lagud. Most observations concern hCT/P and biologics CGMP; the most-cited regulation is 21 CFR 1271.80 (what are the general requirements for donor testing?).

At a glance

HCT/P and biologics cgmp account for 2 of 2 observations.

HCT/P1
Biologics CGMP1

Most cited: 21 CFR 1271.80(c) (1×) · 606.100(c) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Testing for communicable disease agents was not performed in accordance…

  2. 02

    Failure to perform a thorough investigation and make a record of the conclusions and follow-up…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Creative Testing Solutions?

FDA listed 2 observations on this Form 483, mostly about hCT/P and biologics CGMP. The most-cited regulation is 21 CFR 1271.80 (what are the general requirements for donor testing?). The opening words of each observation are shown on this page.

Who inspected Creative Testing Solutions?

Emily S. McGann and William F. Lagud are named on this Form 483, for the inspection of Aug 18 – Aug 29, 2025. Each investigator has a profile showing what they cite most.

When was Creative Testing Solutions inspected by FDA?

The inspection ran Aug 18 – Aug 29, 2025, and the Form 483 is dated August 29, 2025.

How do I get the full Form 483 for Creative Testing Solutions?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free